Jose Antonio Lopez-Escamez

Prof. Jose Antonio Lopez-Escamez

School of Medical Sciences, FMH, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Journal of Vestibular Research
Verified
Journal Article
Closed access
PDF file
Jose Antonio Lopez-EscamezJose Antonio Lopez-Escamez
Jose Antonio Lopez-Escamez
JCJohn Carey
John Carey
WCWon-Ho Chung
Won-Ho Chung
JGJoel A. Goebel
Joel A. Goebel
MMMåns Magnusson
Måns Magnusson
ABAlexandre Bisdorff
Alexandre Bisdorff
This paper presents diagnostic criteria for Menière's disease jointly formulated by the Classification Committee of the Bárány Society, The Japan Society for Equilibrium Research, the European Academy of Otology and Neurotology (EAONO), the Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the Korean Balance Society. The classification includes two categories: definite Menière's disease and probable Menière's disease. The diagnosis of definite Menière's disease is based on clinical criteria and requires the observation of an episodic vertigo syndrome associated with low- to medium-frequency sensorineural hearing loss and fluctuating aural symptoms (hearing, tinnitus and/or fullness) in the affected ear. Duration of vertigo episodes is limited to a period between 20 minutes and 12 hours. Probable Menière's disease is a broader concept defined by episodic vestibular symptoms (vertigo or dizziness) associated with fluctuating aural symptoms occurring in a period from 20 minutes to 24 hours.

1 January 2021
Verified
Book Chapter
Closed access
DRDirk De Ridder
Dirk De Ridder
WSWinfried Schlee
Winfried Schlee
SVSven Vanneste
Sven Vanneste
ALAlain Londero
Alain Londero
NWNathan Weisz
Nathan Weisz
BLBerthold Langguth
Berthold Langguth

27 January 2017 in Journal of Vestibular Research
Verified
Journal Article
Open access
PDF file
MSMichael Strupp
Michael Strupp
Jose Antonio Lopez-EscamezJose Antonio Lopez-Escamez
Jose Antonio Lopez-Escamez
JKJi-Soo Kim
Ji-Soo Kim
DSDominik Straumann
Dominik Straumann
JJJoanna C. Jen
Joanna C. Jen
TBThomas Brandt
Thomas Brandt
This paper describes the diagnostic criteria for vestibular paroxysmia (VP) as defined by the Classification Committee of the Bárány Society. The diagnosis of VP is mainly based on the patient history and requires: A) at least ten attacks of spontaneous spinning or non-spinning vertigo; B) duration less than 1 minute; C) stereotyped phenomenology in a particular patient; D) response to a treatment with carbamazepine/oxcarbazepine; and F) not better accounted for by another diagnosis. Probable VP is defined as follows: A) at least five attacks of spinning or non-spinning vertigo; B) duration less than 5 minutes; C) spontaneous occurrence or provoked by certain head-movements; D) stereotyped phenomenology in a particular patient; E) not better accounted for by another diagnosis. Ephaptic discharges in the proximal part of the 8th cranial nerve, which is covered by oligodendrocytes, are the assumed mechanism. Important differential diagnoses are Menière’s disease, vestibular migraine, benign paroxysmal positional vertigo, epileptic vestibular aura, paroxysmal brainstem attacks (in multiple sclerosis or after brainstem stroke), superior canal dehiscence syndrome, perilymph fistula, transient ischemic attacks and panic attacks. Current areas of uncertainty in the diagnosis of VP are: a) MRI findings of vascular compression which are not diagnostic of the disease or predictive for the affected side because they are also observed in about 30% of healthy asymptomatic subjects; and b) response to treatment with carbamazepine/oxcarbazepine supports the diagnosis but there are so far no randomized controlled trials for treatment of VP.

6 February 2015 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
JEJuan Manuel Espinosa-Sanchez
Juan Manuel Espinosa-Sanchez
Jose Antonio Lopez-EscamezJose Antonio Lopez-Escamez
Jose Antonio Lopez-Escamez
Vestibular migraine (VM) is a common disorder in which genetic, epigenetic and environmental factors probably contribute to its development. The pathophysiology of VM is unknown; nevertheless in the last few years, several studies are contributing to understand the neurophysiological pathways involved in VM. The current hypotheses are mostly based on the knowledge of migraine itself. The evidence of trigeminal innervation of the labyrinth vessels and the localization of vasoactive neuropeptides in the perivascular afferent terminals of these trigeminal fibers support the involvement of the trigemino-vascular system. The neurogenic inflammation triggered by activation of the trigeminal-vestibulocochlear reflex, with the subsequent inner ear plasma protein extravasation and the release of inflammatory mediators, can contribute to a sustained activation and sensitization of the trigeminal primary afferent neurons explaining VM symptoms. The reciprocal connections between brainstem vestibular nuclei and the structures that modulate trigeminal nociceptive inputs (rostral ventromedial medulla, ventrolateral periaqueductal grey, locus coeruleus and nucleus raphe magnus) are critical to understand the pathophysiology of VM. Although cortical spreading depression can affect cortical areas involved in processing vestibular information, functional neuroimaging techniques suggest a dysmodulation in the multimodal sensory integration and processing of vestibular and nociceptive information, resulting from a vestibulo-thalamo-cortical dysfunction, as the pathogenic mechanism underlying VM. The elevated prevalence of VM suggests that multiple functional variants may confer a genetic susceptibility leading to a dysregulation of excitatory-inhibitory balance in brain structures involved in the processing of sensory information, vestibular inputs and pain. The interactions among several functional and structural neural networks could explain the pathogenic mechanisms of VM.

26 February 2017 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
LFLidia Frejo
Lidia Frejo
Eduardo Martin-SanzEduardo Martin-Sanz
Eduardo Martin-Sanz
Roberto TeggiRoberto Teggi
Roberto Teggi
GTGabriel Trinidad-Ruiz
Gabriel Trinidad-Ruiz
ASA. Soto‐Varela
A. Soto‐Varela
T(the Meniere's disease Consortium (MeDiC)
the Meniere's disease Consortium (MeDiC)

16 November 2004 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
Jose Antonio Lopez-EscamezJose Antonio Lopez-Escamez
Jose Antonio Lopez-Escamez
MGMaria J. Gamiz
Maria J. Gamiz
AFAntonio Fernandez-Perez
Antonio Fernandez-Perez
MGManuel Gomez-Fiñana
Manuel Gomez-Fiñana